Abstract
Given the alarming opioid epidemic, high prevalence of parents involved in substance use treatment programs for opioid use disorder, and critical role that parenting stress plays on opioid use and relapse, the current study examines stressors experienced by mothers enrolled in substance use treatment. Specifically, interviews were conducted with mothers with opioid use disorder (OUD) enrolled in an inpatient substance use treatment program, to identify common themes and develop recommendations related to interventions targeting common stressors among this population. A significant number of parent-related, substance use-related, and other stressors were present prior to and during substance use treatment; with more stressors reported during treatment than prior to treatment. Mothers with OUD reported that they would be interested in receiving parenting services, but that relevant parenting resources were not offered during substance use treatment.
Similar content being viewed by others
References
Almeida, D. M., Neupert, S. D., Banks, S. R., & Serido, J. (2005). Do daily stress processes account for socioeconomic health disparities?The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 60(Special_Issue_2), S34–S39.
Ashley, O. S., Marsden, M. E., & Brady, T. M. (2003). Effectiveness of substance abuse treatment programming for women: A review. The American Journal of Drug and Alcohol Abuse,29(1), 19–53.
Bateman, B. T., Hernandez-Diaz, S., Rathmell, J. P., Seeger, J. D., Doherty, M., Fischer, M. A., et al. (2014). Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. The Journal of the American Society of Anesthesiologists,120, 1216–1224.
Bohnert, A. S., Valenstein, M., Bair, M. J., et al. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 305(13), 1315–1321.
Boyatzis, R. E. (1998). Transforming qualitative information: Thematic analysis and code development. New York: Sage.
Briggs, G. C., Freeman, R. K., & Yaffe, S. J. (2008). Drugs in pregnancy and lactation: A reference guide to fetal and maternal risk. Obstetric Medicine. https://doi.org/10.1258/om.2009.090002.
Coalescing on Women and Substance Use (2007) Mothers and the substance use treatment system. Information Sheet No. 3 [Mothering and Substance Use Information Sheets]. Retrieved December 4, 2017, from http://www.coalescing-vc.org/virtualLearning/community3/documents/MotheringandSubstanceUseinfosheet3.pdf.
DeCuir-Gunby, J. T., Marshall, P. L., & McCulloch, A. W. (2011). Developing and using a codebook for the analysis of interview data: An example from a professional development research project. Field Methods,23(2), 136–155.
Desai, R. J., Hernandez-Diaz, S., Bateman, B. T., & Huybrechts, K. F. (2014). Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstetrics and Gynecology,123, 997.
Ehde, D. M., Dillworth, T. M., & Turner, J. A. (2014). Cognitive-behavioral therapy for individuals with chronic pain: Efficacy, innovations, and directions for research. American Psychologist,69, 153.
Elo, S., & Kyngäs, H. (2008). The qualitative content analysis process. Journal of Advanced Nursing,62, 107–115.
Fischer, G., Ortner, R., Rohrmeister, K., Jagsch, R., Baewert, A., Langer, M., et al. (2006). Methadone versus buprenorphine in pregnant addicts: A double blind, double-dummy comparison study. Addiction,101(2), 275–281.
Fox, J. K., Halpern, L. F., Ryan, J. L., & Lowe, K. A. (2010). Stressful life events and the tripartite model: Relations to anxiety and depression in adolescent females. Journal of Adolescence, 33(1), 43–54.
Glaser, B. G., & Strauss, A. (1967). The discovery of ground theory. New York: Alpine.
Haight, S. C., Ko, J. Y., Tong, V. T., Bohm, M. K., & Callaghan, W. M. (2018). Opioid use disorder documented at delivery hospitalization—United States, 1999-2014. Morbidity and Mortality Weekly Report,67(31), 845–849.
Hughes, A., Williams, M., Lipari, R., Bose, J., Copello, E., & Kroutil, L. (2016). Prescription drug use and misuse in the United States: Results from the 2015 National Survey on Drug Use and Health (pp. A1–A24). National Survey on Drug Use and Health Data Review.
Jansson, L. M., Svikis, D. S., & Beilenson, P. (2003). Effectiveness of child case management services for offspring of drug-dependent women. Substance Use and Misuse,38(14), 1933–1952.
Jones, H. E., Deppen, K., Hudak, M. L., et al. (2014). Clinical care for opioid-using pregnant and postpartum women: The role of obstetric providers. American Journal of Obstetrics and Gynecology,210(4), 302–310.
Jones, H. E., & Fielder, A. (2015). Neonatal abstinence syndrome: Historical perspective, current focus, future directions. Preventive Medicine,80, 12–17.
Koob, G. F., & Le Moal, M. (1987). Drug abuse: Hedonic homeostatic dysregulation. Science,278(5335), 52–58.
Kumpfer, K. L., & Fowler, M. A. (2007) Parenting skills and family support programs for drug abusing mothers. In Seminars in fetal and neonatal medicine (Vol. 12(2), pp. 134–142). WB Saunders.
LaGasse, L. L., Messinger, D., Lester, B. M., et al. (2003). Prenatal drug exposure and maternal and infant feeding behaviour. Archives of Disease in Childhood-Fetal and Neonatal Edition,88(5), F391–F399.
Lander, L. R., Gurka, K. K., Marshalek, P. J., Riffon, M., & Sullivan, C. R. (2015). A comparison of pregnancy-only versus mixed-gender group therapy among pregnant women with opioid use disorder. Social Work Research,39(4), 235–244.
Lester, B. M., Tronick, E. Z., & Brazelton, T. B. (2004). The neonatal intensive care unit network neurobehavioral scale procedures. Pediatrics,113, 641–667.
Leventhal, H., & Cleary, P. D. (1980). The smoking problem: A review of the research and theory in behavioral risk modification. Psychological Bulletin,88(2), 370.
Madigan, S., Moran, G., & Pederson, D. R. (2006). Unresolved states of mind, disorganized attachment relationships, and disrupted interactions of adolescent mothers and their infants. Developmental Psychology,42(2), 293.
Marlatt, G. A., & Gordon, J. R. (1985). Relapse prevention: Maintenance strategies in addictive behavior change. New York: Guilford.
Miczek, K. A., Mutschler, N. H., van Erp, A. M., Blank, A. D., & McInerney, S. C. (1999). d-Amphetamine “cue” generalizes to social defeat stress: Behavioral sensitization and attenuated accumbens dopamine. Psychopharmacology, 147(2), 190–199.
Minozzi, S., Amato, L., Vecchi, S., & Davoli, M. (2008). Maintenance agonist treatments for opiate dependent pregnant women. The Cochrane Library,16, CD006318.
Nair, P., Schuler, M. E., Black, M. M., Kettinger, L., & Harrington, D. (2003). Cumulative environmental risk in substance abusing women: Early intervention, parenting stress, child abuse potential and child development. Child Abuse and Neglect,27(9), 997–1017.
National Institute on Drug Abuse. (2017). Medication assisted treatment for opioid addiction. Retrieved December 4, 2017, from http://www.drugabuse.gov/publications/topics-in-brief/medication-assisted-treatment-opioid-addiction.
National Institutes of Health. (2018). NIH launches HEAL initiative, doubles funding to accelerate scientific solutions to stem national opioid epidemic. Retrieved from https://www.nih.gov/news-events/news-releases/nih-launches-heal-initiative-doubles-funding-acceleratescientific-solutions-stem-nationalopioid-epidemic.
O’Brien, C. M., & Jeffery, H. E. (2002). Sleep deprivation, disorganization and fragmentation during opiate withdrawal in newborns. Journal of Pediatrics and Child Health,38(1), 66–71.
Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA,307(18), 1934–1940.
Piazza, P. V., & Le Moal, M. (1997). Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annual Review of Pharmacology and Toxicology, 36(1), 359–378.
Rudd, R. A. (2016). Increases in drug and opioid-involved overdose deaths—United States, 2010–2015 (p. 65). MMWR Morbidity and Mortality Weekly Report.
Russell, J. A., & Mehrabian, A. (1997). The mediating role of emotions in alcohol use. Journal of Studies on Alcohol,36(11), 1508–1536.
Short, V. L., Gannon, M., Weingarten, W., Kaltenbach, K., LaNoue, M., & Abatemarco, D. J. (2017). Reducing stress among mothers in drug treatment: A description of a mindfulness-based parenting intervention. Maternal and Child Health Journal,21(6), 1377–1386.
Simpson, M., & McNulty, J. (2008). Different needs: Women’s drug use and treatment in the UK. International Journal of Drug Policy,19(2), 169–175.
Sinha, R. (2001). How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl),158(4), 343–359.
South Carolina Department of Health and Human Services. (2016). Treatment options for opioid substance use in pregnant and postpartum women. Presentation at the South Carolina Birth Outcomes Initiative, Columbia, SC
Substance Abuse and Mental Health Services Administration. (2002). Results from the 2001 National Household Survey on Drug Abuse. NHSDA Series H-17, DHHS Publication No. @MA 02-3758. Rockville, MD: Office of Applied Studies.
Sword, W., Jack, S., Niccols, A., Milligan, K., Henderson, J., & Thabane, L. (2009). Integrated programs for women with substance use issues and their children: A qualitative meta-synthesis of processes and outcomes. Harm Reduction Journal,6(1), 1–32.
Trull, T. J., Sher, K. J., Minks-Brown, C., Durbin, J., & Burr, R. (2000). Borderline personality disorder and substance use disorders: A review and integration. Clinical Psychology Review, 20(2), 235–253.
Velez, M., & Jansson, L. M. (2008). The opioid dependent mother and newborn dyad: Non-pharmacologic care. Journal of Addiction Medicine,2(3), 113.
Webster, L. R. (2017). Risk factors for opioid-use disorder and overdose. Anesthesia & Analgesia, 125(5), 1741–1748.
Williams, A. C. D. C., Eccleston, C., & Morley, S. (2012). Psychological therapies for the management of chronic pain (excluding headache) in adults. The Cochrane Library,11, CD007407.
Wills, T. A., & Shiffman, S. (1985). Coping and substance use: A conceptual framework. In Coping and substance use (pp. 3–24).
Women’s Service Strategy Work Group. (2005). Best practices in action: Guidelines and criteria for women’s substance abuse services in Ontario. Toronto: Ministry of Health and Long Term Care.
Acknowledgements
This study was supported by Grant 5K12DA031794-03 to support the first author, as well as by NIH Grants P50DA016511, R01DA021690, and K24DA038240 to support work by the last author.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest to report and authors certify all responsibility for the manuscript.
Ethical Approval
University IRB approval was obtained and adhered to. Informed consent was obtained for all human subjects research; the research did not involve animals.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Moreland, A., Hartley, C., DelMas, S. et al. Examining Stressors and Available Parenting Resources for Opioid-Using Mothers: Qualitative Findings from an Inpatient Substance Use Treatment Program. Community Ment Health J 56, 426–434 (2020). https://doi.org/10.1007/s10597-019-00478-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-019-00478-6